Fund HoldingsCAXTON CORP

Total Portfolio Value
$9.85M
Total Bought
$4.79M
Total Sold
$62.7K
Net Transaction
+$4.72M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
REZOLUTE INC1,318,9671,603,986+285,0193,8257,15472.60%+3,329
SPDR GOLD TR(GLD)1,2984,952+3,6543741,51015.32%+1,135
ENLIVEN THERAPEUTICS INC013,097+13,09702632.67%+263
BERKSHIRE HATHAWAY INC DEL467632+1652493073.12%+58
COMPASS THERAPEUTICS INC43,46543,4650831131.15%+30
KYVERNA THERAPEUTICS INC22,98122,981044710.72%+26
MIND MEDICINE MINDMED INC34,07334,07301992212.24%+22
LEXEO THERAPEUTICS INC17,85117,332-51962700.71%+8
CONTEXT THERAPEUTICS INC18,40318,403011120.12%+1
INHIBIKASE THERAPEUTICS INC16,39316,393036320.32%-4
ADICET BIO INC17,4880-17,488130-13
BICARA THERAPEUTICS INC10,94110,94101431021.03%-41
CARDIFF ONCOLOGY INC13,2870-13,287420-42
Page 1 of 1